ArticleDisease models & mechanisms2026

Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cells.

Nicole R West et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.